Protagonist Therapeutics
Brisbane
About Protagonist Therapeutics
Protagonist Therapeutics is a biotechnology company dedicated to the discovery of novel peptide and small molecule compounds that mimic or inhibit therapeutically-relevant protein-protein interactions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $389.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2021)
- Ticker: nasdaq:PTGX
- Website: protagonist-inc.com
- Phone: 61 7 3346 2975
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/protagonist-therapeutics-10324 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.